Panel of black doctors created to vet FDA approval of coronavirus vaccine


A panel of black doctors has been created to vet the US Food and Drug Administration’s approval of coronavirus vaccines.

The move by the National Medical Association, the oldest group of black physicians in the US, has been triggered by fears that decisions would be based on political expediency rather than science.

Similar fears have been voiced by New York governor, Andrew Cuomo, who said the state would independently vet vaccines approvedby the federal government.

An Axios-Ipsos poll last month showed that only 28 per cent of black Americans would be willing to take a first-generation Covid-19 vaccine, compared with 51 per cent of whites and 56 per cent of Hispanics.

African-Americans are reluctant to be early adopters of the vaccine even though the latest figures, released by the Centres for Disease Control last month, showed that they were more than twice as likely to die of Covid-19 than white people.

“Within the African-American community there is a mistrust dating back to the Tuskegee syphilis study,” a spokesman for the Association told the Telegraph.

In that study, which ran from 1932-1972, hundreds of black men, mainly impoverished sharecroppers, were left untreated for syphilis to enable scientists to assess the efficacy of penicillin.

Leon McDougle, the president of the Association, said there were serious questions over whether the FDA’s decisions on approving the vaccine were being dictated by politics.

Under fire over his handling of the coronavirus crisis, Donald Trump has hyped a number of cures in recent months including the use of hydroxychloroquine and convalescent plasma.

In both cases, the FDA bypassed normal safety protocols to give the drugs emergency use authorisation.

The administration has signalled that it wants to fast-track a vaccine under a programme called “Operation Warp Speed.”

Originally Mr Trump set a target date for a safe vaccine to be delivered by next January.

That has been brought forward triggering fears among scientists the FDA will be under pressure to ease vetting requirements to enable a vaccine to be announced ahead of the election.

“Questions of political influence on the scientific process because of Operation Warp Speed have threatened the public trust in the FDA,” Mr. McDougle said. “That will adversely affect participation in clinical trials, especially in the African-American community.”

The NMA task force will provide recommendations to the FDA and doctors about the deployment of vaccines and treatments undergoing clinical trials, he added.

Last week FDA Commissioner Stephen Hahn pledged that the administration’s decisions would be based “on science and data, not politics.”


Related Businesses
    - - Customer

    Copyright © 2024 by CreditRiskMonitor.com (Ticker: CRMZ®). All rights reserved.  You are not permitted to use this report or the information contained herein for any purpose not expressly permitted by CreditRiskMonitor.com, Inc. Except as expressly permitted by CreditRiskMonitor.com, Inc., you are not permitted, in whole or in part, to copy, alter, correct, adapt, translate, enhance, lease, sell, sublicense, assign, distribute, publish, otherwise make available to any third party, or prepare derivative works or improvements of this report or any of the information contained therein. You are not permitted to reverse engineer, disassemble, decompile, decode, or adapt the software, algorithms or other processes used to prepare this report, or otherwise attempt to derive or gain access to the source code of same. You agree not to remove, alter, obscure, combine or otherwise change any disclaimers, trademarks, copyrights, other intellectual property rights, proprietary rights, or other symbols, notices, marks, or serial numbers on or relating to any copy of the report or on marketing or other materials that CreditRiskMonitor.com, Inc. may provide to you. You will not use this report in any manner or for any purpose that infringes, misappropriates, or otherwise violates any right of any party, or that violates any applicable law.  
    The FRISK® scores, agency ratings, credit limit recommendations and other scores, analysis and commentary are opinions of CreditRiskMonitor.com, Inc. and/or its suppliers, not statements of fact, and should be one of several factors in making credit decisions.  Any reliance you place on the information in this report is strictly at your own risk. Except as expressly provided by CreditRiskMonitor.com, Inc., no warranties or representations of any type, including without limitation of results to be obtained, merchantability or fitness for a particular purpose, are made concerning any part of CreditRiskMonitor.com, Inc.’s service, including without limitation the FRISK® scores.  The information published above has been obtained from sources CreditRiskMonitor considers to be reliable.  CreditRiskMonitor.com, Inc. and its third-party suppliers do not guarantee or validate the accuracy and completeness of the information provided in this report, the underlying information input to create the FRISK® scores, and specifically do not assume responsibility for not reporting any information omitted or withheld.  By using this website, you accept the Terms of Use Agreement
    Contact Us: 845.230.3000
    Fundamental financial data concerning public companies may be provided by Refinitiv (click for restrictions)
    Friday, March 29, 2024